Early A{beta} accumulation is associated with distinct gut microbial signatures and reduced neuroactive metabolic potential, identifying targets for potential preclinical AD intervention.
Abstract
INTRODUCTION: Alzheimer's disease (AD) begins with cerebral amyloid-beta (A{beta}) deposition decades before clinical symptoms. While the microbiota-gut-brain axis has been implicated in AD, its role in this preclinical phase remains unclear. We examined potential links between gut microbiome features and presymptomatic cerebral A{beta} burden.
Methods
Asymptomatic individuals (n=101, median age 70.0 years, 53% female) underwent cognitive assessment, cerebral A{beta} quantification, and stool metagenomic sequencing. Associations between microbial characteristics and A{beta} levels were performed using multivariable-adjusted ordinal logistic regression.
Results
Gut microbiota composition varied with A{beta} levels (p(perm)=0.03, R2=0.014). Higher A{beta} was associated with increased Alistipes communis, and decreased Anaerotignum faecicola and Eubacterium rectale, abundance (q<0.001). A{beta}-associated microbiome traits corresponded to lower biosynthetic capacity for {gamma}-aminobutyric acid, and systemic regulators of immunity and autophagy (q<0.01).
Discussion
Early A{beta} accumulation is associated with distinct gut microbial signatures and reduced neuroactive metabolic potential, identifying targets for potential preclinical AD intervention.
AD in this Central Asian cohort was associated with a less diverse, compositionally distinct gut microbiome, with depletion of butyrate-producing Firmicutes and enrichment of sulfate-reducing taxa, alongside other taxa whose direction of association differed from prior reports.
A. Issilbayeva, S. Kozhakhmetov, A. Kushugulova et al.· International Journal of Mol...· 0 citations
This paper examines the role of gut microbiota in the pathogenesis of Alzheimer's disease (AD) and discusses the specific mechanisms by which gut microbiota can influence the brain. Particular attention is paid to the gut-brain axis as a key pathway for this communication.
An analysis of the literature reveals that a p...
Е. E. (Zueva), O. Gizinger· Terapevt (General Physician)· 0 citations
Background/Objectives: Cerebral small vessel disease (CSVD) is a major vascular component of brain aging, yet potentially modifiable systemic contributors remain incompletely understood. Growing evidence links the gut microbiome to magnetic resonance imaging (MRI)-defined CSVD, but interpretation is complicated by hete...
Tamás Jarecsny, Ferenc Fazekas, N. Al-Muhanna et al.· Nutrients· 0 citations
Research on gut microbiota in Alzheimer’s disease (AD) has progressed from observational correlation studies toward investigation of causal relationships in preclinical models. Human observational studies have reported associations between alterations in gut microbiota and the entire spectrum of AD, from the preclinica...
Shi-Han Chen, Xing-Yu Wang, Jia-Xing Dou et al.· Current Issues in Molecular...· 0 citations
Introduction: Alzheimer's disease is a neurodegenerative disease with a complicated etiology and pathology, many aspects of which are still being investigated. Recent evidence has revealed that the composition of the gut microbiome is implicated in Alzheimer’s pathology, since gut microbes can influence the brain via a...
Eli Rabson· Undergraduate Research in Na...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.